Charles Boorady is the Managing Partner of Health Catalyst Capital Management, LLC (HCC), a New York-based firm investing in transformative healthcare companies applying artificial intelligence, (AI), and other information technology to healthcare end-markets that improve the human condition and improve value. The HCC team includes a deep bench of C-level executives from large healthcare organizations who support thematic development, sourcing innovative new businesses, and create high sustainable value.

Charles has been involved in healthcare investments since 1994, initially with bulge bracket Wall St. firms as an investment research analyst and investment banker. Prior to 1994 he was a consultant with Accenture, leading business process automation and reengineering engagements. He has evaluated, advised, invested in, and served as Chairman or Director in numerous healthcare companies focused on healthcare and healthcare information technology, ranging from start-up through IPO. He also underwrote significant IPOs including while at Goldman Sachs as the sole lead bookrunner analyst on the landmark Anthem demutualization and IPO in October 2001. He also led healthcare investment research teams at Citi and Credit Suisse. As a healthcare analyst he ranked #1 for coverage of Health Care Providers and Services by Forbes magazine which named him among the “Dazzling Dozen” for investment research. He also ranked #1 by Institutional Investor magazine for coverage of Managed Care, for which he maintained a top 3 ranking in the country for over a decade.

Mr. Boorady has an MBA in Analytic Finance and Statistics from The University of Chicago Booth School of Business and a BS in Engineering from Cornell University.